The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, if you're measuring the epigenetic clock in blood, I would actually say that they're on par with not the individual clinical lab tests, so, you know, they're going to be more predictive than if I just look at HbA1c or just look at cholesterol, but we can also combine these clinical tests into a single kind of risk measure, which is what we do with PhenoAge. And then I would say they're actually on par with that.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.